Еffect of PNPLA3, SERPINA1 and HFE genes polymorphisms on the course of nonalcoholic fatty liver disease
- Authors: Sidorenko D.V.1, Nazarov V.D.1, Lapin S.V.1, Emanuel V.L.1, Raikhelson K.L.2, Kovyazina V.P.2
-
Affiliations:
- Pavlov First Saint Petersburg State Medical University
- Saint Petersburg State University
- Issue: Vol 19, No 3 (2021)
- Pages: 58-64
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113425
- DOI: https://doi.org/10.29296/24999490-2021-03-09
- ID: 113425
Cite item
Abstract
Keywords
Full Text
About the authors
Darya Vladimirovna Sidorenko
Pavlov First Saint Petersburg State Medical University
Email: si-do-renko@mail.ru
medical resident
Vladimir Dmitrievich Nazarov
Pavlov First Saint Petersburg State Medical University
Email: nazarov19932@mail.ru
junior researcher
Sergey Vladimirovich Lapin
Pavlov First Saint Petersburg State Medical University
Email: svlapin@mail.ru
Head of the Laboratory.
Vladimir Leonidovich Emanuel
Pavlov First Saint Petersburg State Medical University
Email: vladimirem1@gmail.com
Head of the Department.
Karina Leonidovna Raikhelson
Saint Petersburg State University
Email: kraikhelson@mail.ru
Professor. Scientific and Educational Center of Gastroenterology and Hepatology
Veronika Pavlovna Kovyazina
Saint Petersburg State Universitysenior laboratory assistant. Scientific and Educational Center of Gastroenterology and Hepatology
References
- Aithal G.P., Das K., Chowdhury A. Epidemiology of nonalcoholic fatty liver disease (NAFLD). GI epidemiology: Diseases and clinical methodology. 2nd ed. Wiley-Blackwell. 2014; 357-72
- Пальгова Л.К., Барановский А.Ю., Ушакова Т.И., Юркина А.С., Блинов Д.В. Эпидемиологические особенности неалкогольной жировой болезни печени в Северо-Западном регионе России (результаты открытого многоцентрового проспективного исследования DIREG 2). Вестник СПбГУ. Медицина. 2017; 12 (2): 118-35. doi: 10.21638/11701/spbu11.2017.201
- Kovalic A.J., Banerjee P, Tran Q.T, Singal A.K., Satapathy S.K. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver Disease. J. Clin. Exp. Hepatol. 2018; 8 (4): 390-402. doi: 10.1016/j.jceh.2018.04.001. PMID: 30564000; PMCID: PMC6286466
- Rinella M.E. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313 (22): 2263-73. doi: 10.1001/jama.2015.5370. Erratum in: JAMA. PMID: 26057287.
- Singh S., Allen A.M., Wang Z., Prokop L.J., Murad M.H., Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015; 13 (4): 643-54. e1-9; quiz e39-40. doi: 10.1016/j.cgh.2014.04.014. PMID: 24768810; PMCID: PMC4208976.
- Pais R., Charlotte F., Fedchuk L., Bedossa P, Lebray P., Poynard T, Ratziu V. LIDO Study Group. A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J. Hepatol. 2013; 59 (3): 550-6. doi: 10.1016/j.jhep.2013.04.027. PMID: 23665288.
- Dongiovanni P., Anstee Q.M., Valenti L. Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr Pharm Des. 2013; 19 (29): 5219-38. doi: 10.2174/13816128113199990381. PMID: 23394097; PMCID: PMC3850262.
- Seko Y., Yamaguchi K., Itoh Y. The genetic backgrounds in nonalcoholic fatty liver disease. Clin J. Gastroenterol. 2018; 11 (2): 97-102. DOI: 10.1007/ s12328-018-0841-9. PMID: 29492830.
- Mitsche M.A., Hobbs H.H., Cohen J.C. Patatin-like phospholipase domain-containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets. J. Biol. Chem. 2018; 293 (18): 6958-68. DOI: 10.1074/ jbc.RA118.002333. Erratum in: J Biol Chem. 2018; 293 (24): 9232. PMID: 29555681; PMCID: PMC5936833.
- Тихомирова А.С., Кисляков В.А., Байкова И.Е., Никитин И.Г Клинико-морфологические параллели полиморфизма гена PNPLA3 у пациентов с неалкогольной жировой болезнью печени. Терапевтический архив. 2018 и 85-88, 02. doi: 10.26442/terarkh201890285-88.
- Stoller J.K., Aboussouan L.S. Alpha1-antitrypsin deficiency. Lancet. 2005; 365 (9478): 2225-36. doi: 10.1016/S0140-6736(05)66781-5. PMID: 15978931
- Greene C.M., Marciniak S.J., Teckman J., Ferrarotti I., Brantly M.L., Lomas D.A., Stoller J.K., McElvaney N.G. a1-Antitrypsin deficiency Nat Rev Dis Primers. 2016; 2: 16051. doi: 10.1038/nrdp.2016.51. Erratum in: Nat Rev Dis Primers. 2018; 4 (1): 40. PMID: 27465791
- Valenti L., Dongiovanni P., Fracanzani A.L., Santorelli G., Fatta E., Bertelli C., Taioli E., Fiorelli G., Fargion S. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis. 2003; 35 (3): 172-8. DOI: 10.1016/ s1590-8658(03)00025-2. PMID: 12779071.
- Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis. 1996; 16 (1): 13-30. doi: 10.1055/s-2007-1007215. PMID: 8723320.
- Zezos P., Renner E.L. Liver transplantation and nonalcoholic fatty liver disease. World J. Gastroenterol. 2014; 20 (42): 15532-8. doi: 10.3748/wjg.v20. i42.15532. PMID: 25400437; PMCID: PMC4229518.
- Dai G., Liu P, Li X., Zhou X., He S. Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis. Medicine (Baltimore). 2019; 98 (7): e14324. doi: 10.1097/MD.0000000000014324. PMID: 30762732; PMCID: PMC6407996.
- Hotta K., Yoneda M., Hyogo H., Ochi H., Mizusawa S., Ueno T., Chayama K., Nakajima A., Nakao K., Sekine A. Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease. BMC Med Genet. 2010; 11: 172. doi: 10.1186/1471-235011-172. PMID: 21176169; PMCID: PMC3018434.
- Prins B.P., Kuchenbaecker K.B., Bao Y., Smart M., Zabaneh D., Fatemifar G., Luan J., Wareham N.J., Scott R.A., Perry J.R.B., Langenberg C., Benzeval M., Kumari M., Zeggini E. Genome-wide analysis of health-related biomarkers in the UK Household Longitudinal Study reveals novel associations. Sci Rep. 2017; 7 (1): 11008. doi: 10.1038/s41598-017-10812-1. PMID: 28887542; PMCID: PMC5591265.
- Giambattistelli F., Bucossi S., Salustri C., Panetta V, Mariani S., Siotto M., Ventriglia M., Vernieri F., Dell'acqua M.L., Cassetta E., Rossini P.M., Squitti R. Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease. Neuro-biol Aging. 2012; 33 (8): 1633-41. DOI: 10.1016/j. neurobiolaging.2011.03.005. PMID: 21514009.
- Valenti L., Al-Serri A., Daly A.K., Galmozzi E., Rametta R., Dongiovanni P., Nobili V., Mozzi E., Roviaro G., Vanni E., Bugianesi E., Maggioni M., Fracanzani A.L., Fargion S., Day C.P. Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010; 51 (4): 1209-17. DOI: 10.1002/ hep.23622. PMID: 20373368.
- Hamesch K., Mandorfer M., Pereira VM., Moeller L.S., Pons M., Dolman G.E., Reichert M.C., Schneider C.V, Woditsch V, Voss J., Lindhauer C., Fromme M., Spivak I., Guldiken N., Zhou B., Arslanow A., Schaefer B., Zoller H., Aigner E., Reiberger T, Wetzel M., Siegmund B., Simoes C., Gaspar R., Maia L., Costa D., Bento-Miranda M., van Helden J., Yagmur E., Bzdok D., Stolk J., Gleiber W, Knipel V, Windisch W, Mahadeva R., Bals R., Koczulla R., Barrecheguren M., Miravitlles M., Janciauskiene S., Stickel F, Lammert F, Liberal R., Genesca J., Griffiths W.J., Trauner M., Krag A., Trautwein C., Strnad P. European Alpha1-Liver Study Group. Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-anti-trypsin Deficiency Caused by the Pi*ZZ Mutation. Gastroenterology 2019; 157 (3): 705-19. e18. doi: 10.1053/j.gastro.2019.05.013. PMID: 31121167.
- Ye Q., Qian B.X., Yin WL., Wang F.M., Han T. Association between the HFE C282Y, H63D Polymorphisms and the Risks of Non-Alcoholic Fatty Liver Disease, Liver Cirrhosis and Hepatocellular Carcinoma: An Updated Systematic Review and Meta-Analysis of 5,758 Cases and 14,741 Controls. PLoS One. 2016; 11 (9): 0163423. doi: 10.1371/journal.pone.0163423. PMID: 27657935; PMCID: PMC5033482
- Singal A.G., Manjunath H., Yopp A.C., Beg M.S., Marrero J.A., Gopal P, Waljee A.K. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis. Am. J. Gastroenterol. 2014; 109 (3): 325-34. doi: 10.1038/ajg.2013.476. PMID: 24445574; PMCID: PMC5610907
- Strnad P., Buch S., Hamesch K., Fischer J., Rosendahl J., Schmelz R., Brueckner S., Brosch M., Heimes C.V, Woditsch V, Scholten D., Nischalke H.D., Janciauskiene S., Mandorfer M., Trauner M., Way M.J., McQuillin A., Reichert M.C., Krawczyk M., Casper M., Lammert F., Braun F., von Schonfels W, Hinz S., Burmeister G., Hellerbrand C., Teufel A., Feldman A., Schattenberg J.M., Bantel H., Pathil A., Demir M., Kluwe J., Boettler T, Ridinger M., Wodarz N., Soyka M., Rietschel M., Kiefer F, Weber T., Marhenke S., Vogel A., Hinrichsen H., Canbay A., Schlattjan M., Sosnowsky K., Sarrazin C, von Felden J., Geier A., Deltenre P., Sipos B., Schafmayer C., Nothnagel M., Aigner E., Datz C., Stickel F., Morgan M.Y., Hampe J., Berg T., Trautwein C. Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. 2019; 68 (6): 1099-107. DOI: 10.1136/ gutjnl-2018-316228. PMID: 30068662
- Valenti L., Fracanzani A.L., Dongiovanni P, Bugianesi E., Marchesini G., Manzini P., Vanni E., Fargion S. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am. J. Gastroenterol. 2007; 102 (6): 1251-8. doi: 10.1111/j.1572-0241.2007.01192.x. PMID: 17391316